MagForce AG, a medical device company, operates in the field of nanotechnology-based cancer treatment in Germany. The company offers NanoTherm therapy that treats solid tumors through the intratumoral generation of heat by activating superparamagnetic nanoparticles. It also provides NanoTherm, a ferrofluid liquid containing superparamagnetic iron oxide nanopracticles that is activated in an alternating magnetic field; NanoPlan, a treatment planning software; and NanoActivator, a magnetic field applicator for therapy. The company was founded in 1997 and is headquartered in Berlin, Germany.
magforce ag (MF6:Xetra)
|No competitor information is available for MF6.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact MAGFORCE AG, please visit www.magforce.de. Company data is provided by Capital IQ. Please use this form to report any data issues.